EUVIMEDEUVIMED entdecken
Crossref

Rapid Universal Detection of High‐Risk and Low‐Abundance Microbial Contaminations in CAR‐T Cell Therapy

Xiaolin Wu iD, Joshua Jebaraj Raymond, Yaoping Liu, Alexander Jeremias Odermatt, Wei-Xiang Sin, Denise Bei Lin Teo, Meenubharathi Natarajan, Inn Chuan Ng, Michael E Birnbaum, Timothy K Lu, Jongyoon Han, Stacy L Springs und 1 weitere

Small Methods · 2025

DOI: 10.1002/smtd.202500253 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small Methods, 2025. Verfasst von Xiaolin Wu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Critical Analytics for Manufacturing Personalized Medicine Interdisciplinary Research Group, Singapore-MIT Alliance for Research and Technology Centr…. Hauptthemen laut MEDLINE: Nucleic Acid Amplification Techniques, Immunotherapy, Adoptive, Receptors, Chimeric Antigen, Bacteria. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: National Research Foundation, Prime Minister's Office Singapore, Campus for Research Excellence and Technological Enterprise (CREATE) programme, Singapore MIT Alliance for Research and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Live microbial contamination poses high risks to cell and gene therapies, threatening manufacturing processes and patient safety. Rapid, sensitive detection of live microbes in complex environments, such as CAR‐T cell cultures, remains an urgent need. Here, an innovative sample‐to‐result workflow is introduced using digital loop‐mediated isothermal amplification (dLAMP), enhanced by Electrostatic Microfiltration (EM)‐based enrichment, for rapid sterility testing. By rationally designing primers targeting 16S and 18S rRNA, dLAMP assay enables both universal detection (covering >80% of known species) and strain‐specific identification of bacterial and fungal contaminants in CAR‐T cell spent medium and final products, directly from microorganism lysates. Enhanced by EM‐based enrichment of low‐abundance live microbes, the workflow achieves unparalleled sensitivity and speed, detecting contamination levels as low as 1 CFU/mL in complex CAR‐T cell cultures within 6 h. Compared to qPCR and 14‐day compendial methods, the approach demonstrates superior accuracy and significantly faster turnaround times. This workflow holds transformative potential for real‐time monitoring in cell therapy manufacturing and rapid safety assessments of CAR‐T cell products prior to patient infusion. Beyond cell therapy, the method is broadly applicable to infectious disease diagnostics, biomanufacturing monitoring, food safety, and environmental surveillance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nucleic Acid Amplification TechniquesImmunotherapy, AdoptiveReceptors, Chimeric AntigenBacteriaT-LymphocytesHumansFungiRNA, Ribosomal, 16SRNA, Ribosomal, 18SMolecular Diagnostic Techniques

Stichwörter der Autor:innen

cell therapy sterility testdigital LAMPelectrostatic microfiltrationmultiplex nucleic acid testingquantitative detection of pathogens

Substanzen

Receptors, Chimeric AntigenRNA, Ribosomal, 16SRNA, Ribosomal, 18S

Autor:innen und Institutionen

  • Critical Analytics for Manufacturing Personalized Medicine Interdisciplinary Research Group, Singapore-MIT Alliance for Research and Technology Centre (SMART-CAMP), Singapore, 138602, Singapore.
  • AntiMicrobial Resistance Interdisciplinary Research Group, Singapore-MIT Alliance for Research and Technology Centre (SMART-AMR), Singapore, 138602, Singapore.
  • Swiss Federal Institute of Technology in Lausanne (EPFL), Lausanne, 1015, Switzerland.
  • Department of Physiology & the Institute for Digital Medicine (WisDM), Yong Loo Lin School of Medicine, National University of Singapore (NUS), Singapore, 117593.
  • Department of Biological Engineering, Massachusetts Institute of Technology (MIT), Cambridge, MA, 02139, USA.
  • Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology (MIT), Cambridge, MA, 02139, USA.

ORCID-Profile: Xiaolin Wu, Hanry Yu

Förderung

  • National Research Foundation, Prime Minister's Office Singapore
  • Campus for Research Excellence and Technological Enterprise (CREATE) programme
  • Singapore MIT Alliance for Research and Technology
  • Critical Analytics for Manufacturing Personalised-Medicine (CAMP) Inter-Disciplinary Research Group
  • IAF
  • Mechanobiology Institute, Singapore
  • National Research Foundation Singapore
  • The Institute for Digital Medicine (WisDM)

Zitieren

APA

Wu, X., Raymond, J. J., Liu, Y., Odermatt, A. J., Sin, W. X., Teo, D. B. L., Natarajan, M., Ng, I. C., Birnbaum, M. E., Lu, T. K., Han, J., Springs, S. L., & Yu, H. (2025). Rapid Universal Detection of High‐Risk and Low‐Abundance Microbial Contaminations in CAR‐T Cell Therapy. Small Methods. https://doi.org/10.1002/smtd.202500253

Vancouver

Wu X, Raymond JJ, Liu Y, Odermatt AJ, Sin WX, Teo DBL, et al. Rapid Universal Detection of High‐Risk and Low‐Abundance Microbial Contaminations in CAR‐T Cell Therapy. Small Methods. 2025. doi:10.1002/smtd.202500253

BibTeX
@article{Wu2025,
  author = {Wu, Xiaolin and Raymond, Joshua Jebaraj and Liu, Yaoping and Odermatt, Alexander Jeremias and Sin, Wei-Xiang and Teo, Denise Bei Lin and Natarajan, Meenubharathi and Ng, Inn Chuan and Birnbaum, Michael E and Lu, Timothy K and Han, Jongyoon and Springs, Stacy L and Yu, Hanry},
  title = {Rapid Universal Detection of High‐Risk and Low‐Abundance Microbial Contaminations in CAR‐T Cell Therapy},
  journal = {Small Methods},
  year = {2025},
  doi = {10.1002/smtd.202500253}
}
Kostenlos starten →